Lowell Thomas Holden is CFO at Nascent Biotech Inc. (NBIO). They have made 7 open-market trades across 2 companies since 2015, most recently 2026-03-20.
CIK 0001479734
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
6 open-market purchases totalling $912K since 2015, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SKKY | BUY | 2026-03-20 | 2026-04-06 | $0.28 | $5K | N/A | N/A | N/A |
| NBIO | BUY | 2023-06-07 | 2023-06-09 | $0.04 | $5K | N/A | N/A | N/A |
| NBIO | BUY | 2023-01-27 | 2023-02-02 | $0.14 | $3K | N/A | N/A | N/A |
| NBIO | SELL | 2022-07-21 | 2022-07-25 | $0.26 | $1K | N/A | N/A | N/A |
| SKKY | BUY | 2022-04-08 | 2022-04-11 | $0.17 | $2K | N/A | N/A | N/A |
| NBIO | BUY | 2019-12-26 | 2020-01-06 | $0.17 | $850 | N/A | N/A | N/A |
| NBIO | BUY | 2019-10-03 | 2019-10-07 | $0.14 | $1K | N/A | N/A | N/A |
| NBIO | BUY | 2015-09-04 | 2015-10-13 | $1.45 | $895K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.